DoW Rare Cancers Idea Development Award

Status

Open

Agency

Defense · DOD-AMRAA

Notice

HT942526RCRPIDA

Type

Grant / cooperative agreement

Value

Total program funding: $7,350,000

Deadline

Nov 18, 2026 · confirm cutoff time in notice

Eligibility

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

From the official notice

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should have high potential impact on rare cancers and the patient community.

Source and next steps

Read the official notice and response instructions

This is a sourced opportunity notice. The summary is an excerpt from the issuing agency; amounts and eligibility are taken from its structured record. Check the full notice, amendments and submission requirements before responding.

Source observed 2026-10-20 Eastern. Browse opportunities